Rigshospitalet wants to break the code on patients with immune deficiency A new Research Platform at Rigshospitalet is about to investigate how the treatment of immune defective patients with diagnoses such as Cancer and HIV can be optimized. Rigshospitalet has recently been granted 60 million DKK by the Danish Research Foundation to the project, which is the first of its kind in Denmark. 04. February 2015 kl. 09:05 Responsible editor Webgruppen på Rigshospitalet Please give your consent in order to send your message. Please enter a valid email address. Note: This mail is not secure. Your email should therefore not include civil registration numbers or health information.Read how to send secure digital post:https://www.regionh.dk/securemail Write your message: Write your email (Must be filled out): If you wish to attach one or more files you will need to login first. Create account or log in I hereby give my consent to the Capital Region of Denmark to process the information in my enquiry for professional purposes only. Read the terms for your consent No e-mail has been registred for this user/group